🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of inhaled...
Status
Completed
Location
Pivotal Research Centers
Start Date
2009-03
Trial ID
NCT00871182
Treatments Being Tested
The primary objective of this study is to assess and compare the pharmacoki...
Status
Completed
Location
Teva Investigational Site 32170
Start Date
2013-01
Trial ID
NCT01785433
This study is to characterize the pharmacodynamic characteristics and to as...
Status
Completed
Location
Investigational Site 203
Start Date
2022-03-24
Trial ID
NCT05161156
Chronic obstructive pulmonary disease (COPD) is one of the commonest respir...
Status
Completed
Location
Beijing Chao-Yang Hospital
Start Date
2011-11
Trial ID
NCT01455129
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
Primary Objective: To evaluate the pharmacokinetics and bioequivalence of t...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical University
Start Date
2024-06-10
Trial ID
NCT06487416
Treatments Being Tested
Typically, people with asthma are initially prescribed a low dose of inhale...
Status
Completed
Location
University of California, San Diego
Start Date
2008-05
Trial ID
NCT00565266
Treatments Being Tested
This is a randomised, double-blind, double-dummy, multinational, multicentr...
Status
Completed
Location
205.389.1020 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00563381
Treatments Being Tested
A randomized, placebo-controlled, double-blind, parallel group, multi cente...
Status
Completed
Location
205.477.001039 Boehringer Ingelheim Investigational Site
Start Date
2012-08-01
Trial ID
NCT01663987
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696